Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case

Introduction. In patients with COVID-19, acute pulmonary lesion grows on inflammation and microvascular thrombosis. Thromboinflammation may develop outside alveolar endothelium and affect endothelium of the heart, kidneys, intestine and other vital organs leading to a multiple-organ insufficiency an...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Samorodov, K. N. Zolotukhin
Format: Article
Language:English
Published: Bashkir State Medical University 2020-07-01
Series:Креативная хирургия и онкология
Subjects:
Online Access:https://www.surgonco.ru/jour/article/view/491
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839584556711149568
author A. V. Samorodov
K. N. Zolotukhin
author_facet A. V. Samorodov
K. N. Zolotukhin
author_sort A. V. Samorodov
collection DOAJ
description Introduction. In patients with COVID-19, acute pulmonary lesion grows on inflammation and microvascular thrombosis. Thromboinflammation may develop outside alveolar endothelium and affect endothelium of the heart, kidneys, intestine and other vital organs leading to a multiple-organ insufficiency and possible lethal outcomes. Treatment and prevention of SARS-CoV-2 in the Russian Federation should comply with the Interim Methodological Guidelines of the Russian Ministry of Health that support the global mainstream of COVID-19 containment measures and are updated regularly with new evidence on drug effectiveness, including anticoagulants.Materials and methods. We review a clinical case of effective treatment of a COVID19 patient with prior coronary surgery from the perspective of the Interim Methodical Guidelines of different editions and international clinical experience in anticoagulant therapy.Results and discussion. A retrospective analysis of the patient’s treatment demonstrated the efficacy of thromboelastography in rapid assessment of blood hypercoagulation and parnaparin sodium as a drug of choice among low-molecular heparins in a combined setting with dual antiplatelet therapy. Etiotropic therapy rendered to this patient is currently considered less effective.Conclusion. Combination of anticoagulants with antiaggregants is shown effective under high risks of thrombosis and a background COVID-19 infection, if justified clinically. In cases of complicated diff erential diagnosis, selection of optimal management strategy, anticoagulant and/or antiplatelet therapy monitoring, a good practice is to rely on both the available domestic guidelines and latest meta-analyses combined with international clinical experience.
format Article
id doaj-art-e23f05ee362e491b80ea66f690ec1693
institution Matheson Library
issn 2076-3093
2307-0501
language English
publishDate 2020-07-01
publisher Bashkir State Medical University
record_format Article
series Креативная хирургия и онкология
spelling doaj-art-e23f05ee362e491b80ea66f690ec16932025-08-03T19:48:54ZengBashkir State Medical UniversityКреативная хирургия и онкология2076-30932307-05012020-07-0110213714210.24060/2076-3093-2020-10-2-137-142379Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical CaseA. V. Samorodov0K. N. Zolotukhin1Bashkir State Medical UniversityG.G. Kuvatov Republican Clinical Hospital,Introduction. In patients with COVID-19, acute pulmonary lesion grows on inflammation and microvascular thrombosis. Thromboinflammation may develop outside alveolar endothelium and affect endothelium of the heart, kidneys, intestine and other vital organs leading to a multiple-organ insufficiency and possible lethal outcomes. Treatment and prevention of SARS-CoV-2 in the Russian Federation should comply with the Interim Methodological Guidelines of the Russian Ministry of Health that support the global mainstream of COVID-19 containment measures and are updated regularly with new evidence on drug effectiveness, including anticoagulants.Materials and methods. We review a clinical case of effective treatment of a COVID19 patient with prior coronary surgery from the perspective of the Interim Methodical Guidelines of different editions and international clinical experience in anticoagulant therapy.Results and discussion. A retrospective analysis of the patient’s treatment demonstrated the efficacy of thromboelastography in rapid assessment of blood hypercoagulation and parnaparin sodium as a drug of choice among low-molecular heparins in a combined setting with dual antiplatelet therapy. Etiotropic therapy rendered to this patient is currently considered less effective.Conclusion. Combination of anticoagulants with antiaggregants is shown effective under high risks of thrombosis and a background COVID-19 infection, if justified clinically. In cases of complicated diff erential diagnosis, selection of optimal management strategy, anticoagulant and/or antiplatelet therapy monitoring, a good practice is to rely on both the available domestic guidelines and latest meta-analyses combined with international clinical experience.https://www.surgonco.ru/jour/article/view/491severe acute respiratory syndromecoronavirushaemostasiscoronary artery diseasesstentsanticoagulantsvenous thrombosisthromboembolismdic syndromelow-molecular heparin
spellingShingle A. V. Samorodov
K. N. Zolotukhin
Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case
Креативная хирургия и онкология
severe acute respiratory syndrome
coronavirus
haemostasis
coronary artery diseases
stents
anticoagulants
venous thrombosis
thromboembolism
dic syndrome
low-molecular heparin
title Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case
title_full Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case
title_fullStr Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case
title_full_unstemmed Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case
title_short Prevention of COVID-19-associated Haemostasis Failure in Patient with Stented Coronary Arteries: a Clinical Case
title_sort prevention of covid 19 associated haemostasis failure in patient with stented coronary arteries a clinical case
topic severe acute respiratory syndrome
coronavirus
haemostasis
coronary artery diseases
stents
anticoagulants
venous thrombosis
thromboembolism
dic syndrome
low-molecular heparin
url https://www.surgonco.ru/jour/article/view/491
work_keys_str_mv AT avsamorodov preventionofcovid19associatedhaemostasisfailureinpatientwithstentedcoronaryarteriesaclinicalcase
AT knzolotukhin preventionofcovid19associatedhaemostasisfailureinpatientwithstentedcoronaryarteriesaclinicalcase